The market of pharmaceutical exports in India has been growing at a healthy pace and strengthening its foothold in the global platform for pharma exports. Over the past few years, the exports of pharmaceutical products have grown at a steady pace in India due to various factors like low cost of production, increased compliance with quality standards and a favourable policy environment. These leading markets have helped in the growth, where United States remains the biggest market for the exports of Indian pharmaceuticals, taking approximately one third of the total exports. Other major markets are EU, Africa & South East Asia where Indian generic medicines, vaccines and APIs are highly acceptable because of their cost advantages and global quality standards.

In addition, the industry is shifting to more lucrative segments such as the biosimilars, complex generics and specialty products which are likely to be key growth areas in the future. The Production Linked Incentive (PLI) scheme launched by the government has further strengthened the sector by reducing its import dependence of some of the critical inputs. All in all, the India pharmaceuticals exports market will continue to experience positive growth due to market diversification, innovation and support from the government. With continuing changes in the global healthcare needs, India is ready to contribute even more to meet the health care needs of the world with affordable and quality medicines.

Keeping tabs on this market, India Pharma Outlook has shortlisted the select few companies from this sector that have exhibited an unrelenting pursuit of excellence. By proving their dedication to fulfilling customer expectations and contributing to the market’s evolution through their innovative disposition, these firms are blazing a trail.

We look forward to receiving your feedback and suggestions.